Screening

Metabolic syndrome is a well-established risk factor for cardiovascular disease (CVD) and type 2 diabetes mellitus. It is therefore important to measure blood pressure, body mass index, waist circumference, lipid profile (triglycerides and high-density lipoprotein [HDL]-cholesterol), and fasting glucose levels in patients with type 2 diabetes mellitus or with a family history of dyslipidemia, CVD, or hereditary conditions associated with cardiovascular mortality such as polycystic ovary syndrome, and in cases of childhood obesity.

Use of this content is subject to our disclaimer